EyeBrain is technological and scientific excellence supported by a mission to accompany medical practice and research.
The founding purpose of EyeBrain is to provide medicine as well as clinical research with innovative tools for the functional exploration and analysis of healthy and diseased brain activity. Our mission is to propose an aid to the diagnosis of diseases that are difficult to detect and apprehend.
The EyeBrain mission is to support the fight of practitioners and patients against neurological and psychiatric diseases and learning disorders, with continual innovation as its essential driving force. Innovation is the heart of our business.
The technology and services we develop are the result of collaborations and strong partnerships with leading research laboratories in neuroscience and the best neurology and psychiatry clinical services, such as for example the Pitié-Salpêtrière Hospital in Paris.
Certification
EyeBrain is involved in a continual quality process, which means it can certify its equipment as well as its services and processes to EC standards.The EyeBrain T1 and EyeBrain T2 are therefore class IIa medical devices, CE0459 certified (Revised 12/12/2013).
Transparency
Under the law of 29 December 2011 and the implementing decree called “Sunshine Act”, creating an obligation to publish links between health product companies and health professionals, EyeBrain is required to make public the existence of relationships with the targeted category that involves a benefit in kind or in cash of an amount greater than or equal to ten Euro.
EyeBrain has always acted in the interests of transparency and restricts any such relationship to comply with the law. To learn more about the Sunshine Act, do not hesitate to consult the following information space.
All EyeBrain information is available at the following address:
www.transparence.sante.gouv.fr